NCT05361447View on ClinicalTrials.gov

Diazepam Trial in GAD65 Associated Epilepsy

PHASE1/PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

January 11, 2023

Primary Completion Date

December 13, 2024

Study Completion Date

December 13, 2024

Conditions

GAD 65 Antibody-associated Epilepsy

Interventions

DRUG

Diazepam

5 mg twice daily oral for 1 week and then increase to 10 mg twice daily oral

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER